Treatment of Alopecia Areata in the United States: A Retrospective Cross-Sectional Study.
| Autor: | Farhangian ME, McMichael AJ, Huang KE, Feldman SR |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2015 Sep; Vol. 14 (9), pp. 1012-4. |
| Abstrakt: | Background: Alopecia Areata (AA) is a non-scarring alopecia that affects millions of Americans, however the way it is treated and which patients seek treatment is not well characterized. Objective: To better understand how AA was being treated in the United States, what type of patients are seen for AA, and what physicians treated them. Methods: We analyzed data from the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2001 to 2010. We tabulated patient characteristics, the physicians who treated AA and what treatments were prescribed for AA. Results: There were an estimated 2.6 million outpatient visits for AA. Patients with AA were most commonly treated by a dermatologists (84.8%). Patients were most commonly treated with topical and injected corticosteroids (61.0%) followed by minoxidil (5.9%) and topical tacrolimus (5.7%). Males made fewer visits per 1,000 capita compared to females (P=0.01). Limitations: The NAMCS and NHAMCS do not record severity of disease data. Conclusions: Topical and injected corticosteroids are the mainstay of treatment for AA, however the use of steroid sparing agents such as minoxidil is low. Despite no studies demonstrating efficacy, topical tacrolimus was used almost as frequently as minoxidil. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|